![Magnus Hansson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Magnus Hansson
Hoofd Techniek/Wetenschap/O&O bij
ABLIVA AB
Profiel
Magnus Hansson is currently the Chief Medical Officer & VP-Preclinical Development at Abliva AB since 2016.
Previously, he worked as an Associate Professor at Skane University Hospital from 2008 to 2015.
Dr. Hansson obtained a doctorate degree from the University of Lund.
Actieve functies van Magnus Hansson
| Bedrijven | Functie | Begin |
|---|---|---|
| ABLIVA AB | Hoofd Techniek/Wetenschap/O&O | 01-01-2016 |
Eerdere bekende functies van Magnus Hansson
| Bedrijven | Functie | Einde |
|---|---|---|
Skane University Hospital
 Skane University Hospital Hospital/Nursing ManagementHealth Services Operates as an hospital | Corporate Officer/Principal | 01-12-2015 |
Opleiding van Magnus Hansson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
27
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Abliva AB
 Abliva AB Pharmaceuticals: MajorHealth Technology Develops medicines for the treatment of mitochondrial diseases | Health Technology |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Skane University Hospital
Skane University Hospital Hospital/Nursing ManagementHealth Services Operates as an hospital | Health Services |
